Looks like the road ahead for America and the politicians who will tell you what drug or test you will and will not be allowed to have. This is bond to happen because government has made a mess of any program we have let them take over.
British cancer patients are missing out on the latest and best drugs because the NHS lacks the capacity to exploit them, one of the country’s most senior medical scientists has told The Times.
The introduction of a new generation of powerful cancer therapies is being held up by poor access to critical genetic tests, according to Sir John Bell, Regius Professor of Medicine at Oxford University and President of the Academy of Medical Sciences.
The new medicines, such as Iressa (gefitinib) for lung cancer and Erbitux (cetuximab) for colorectal cancer, can be highly effective, but against tumours only with a particular genetic profile. DNA tests are needed before they can be prescribed.
While several of these drugs are licensed in Britain, they are rarely used by the NHS because there is no system for commissioning the genetic tests, Sir John said. The science and technology were “ready to rock’n’ roll” and it was time for ministers to “get with the programme”.